Category: Oncology · Cancer staging · Waiting for tests and treatment

How Fast Does Cancer Progress From Stage 1 to 2 to 3? Tumour Doubling Time, What Drives Speed, and Whether Waiting for Tests Is Dangerous

AI Overview / Quick Answer (BLUF)

Cancer grows by repeated cell division, and its speed is measured by volume doubling time, which ranges from days to years by type and grade. Most common solid tumours grow over months to years, so a few weeks of planned workup rarely changes stage, but avoidable delay still matters.

What this article covers:
the period when you are waiting for biopsy results, scans for cancer staging (TNM), or a treatment slot, and worry the cancer will move to the next stage in the meantime —
how fast cancers grow, what doubling time means, why stage is not size, what a few weeks of waiting really means, and what you can do while waiting.
If you need to move hospitals after a biopsy, read
Breast lump with irregular mammogram: biopsy guide and how to transfer hospitals without restarting.
If you are being referred to a cancer centre, read
Cervical cancer referral to Lampang Cancer Hospital: rights, radiation steps, and lodging ·
Red flags ·
Doubling time ·
Is waiting dangerous? ·
Wait vs expedite table ·
FAQ

A question from a cancer patient group: does cancer spread from stage 1 to 2 to 3 in weeks or months?

Direct answer: there is no single number that fits every cancer. Speed depends on the cancer type, subtype, grade, and the individual.
Many common solid tumours grow over months to years, but some cancers are fast and can change over weeks.
And stage does not depend on size alone — so it cannot be answered with a fixed number of weeks.

A member of a Thai cancer patient group asked: “Can cancer spread from stage 1 to 2 to 3 in a few weeks, or does it take months?”
This question comes up constantly while people wait for biopsy results, scans, or a treatment slot. The worry is understandable. This article summarises the research so you can see the real picture — neither frightening nor falsely reassuring.

This article answers in order: (1) why cancer speed has no single answer (2) doubling time and research numbers (3) why stage is not a size ladder
(4) how risky a few weeks of workup is, and which delays to avoid (5) what you can do while waiting (6) when not to wait at all

1. Why cancer speed has no single answer

Direct answer: cancer is not one disease but hundreds of diseases that grow at very different speeds.
The same cancer with a different subtype or grade can grow at very different rates, and two people with the same cancer may not behave the same way.

Cancers that are mostly slow to moderate (months to years)

  • Hormone-positive (luminal) breast cancer — in a study measuring size while waiting for surgery, these grew only about 0.18–0.21% per day
    (Lee 2016)
  • Colorectal cancer — untreated patients had a median doubling time of 211 days
    (Burke 2020)
  • Many PSA-detected localised prostate cancers — in the ProtecT trial, after 15 years only 2.7% died of prostate cancer, whether assigned to monitoring, surgery, or radiotherapy.
    But metastases developed in 9.4% of the monitoring group versus 4.7–5.0% of the treated groups, so regular follow-up is still needed
    (Hamdy 2023)

Cancers that often grow fast (can change over weeks)

  • Small-cell lung cancer, Burkitt lymphoma, and testicular germ-cell tumours —
    classed as rapidly growing cancers (Harris 2012), along with some other high-grade lymphomas
  • Acute leukaemia — the US National Cancer Institute notes that AML usually gets worse quickly if it is not treated
    (NCI)
  • Triple-negative, HER2-positive, or high-grade breast cancer — grows several times faster than hormone-positive types
    (Lee 2016;
    Dahan 2021)

What determines speed

  • Cancer type and organ of origin — some blood and lymph cancers are faster than most solid tumours
  • Grade and proliferation rate — high grade or a high Ki-67 index means cells divide quickly
  • Molecular subtype — for example triple-negative and HER2-positive versus luminal breast cancer
  • Size and growth phase — tumours often slow as they get larger; in liver cancer, smaller tumours tended to grow faster
  • The individual — even within one cancer type, some tumours grow fast while others barely grow over the same period

2. What doubling time is, and real numbers from research

Direct answer: doubling time is the time it takes a tumour to double in volume, and it ranges from days to years.
There is no single average, such as “2–6 months”, that applies to every cancer. The numbers below come from type-specific studies, and each has a wide range.

Verified numbers from research

98 days
Median doubling time of 111 lung cancers found on annual CT screening — half were under 100 days and 3% over 400 days (Henschke 2012)
4.6 months
Pooled value for hepatocellular carcinoma across 20 studies — 35% rapid (under 3 months), 37.6% indolent (over 9 months); Asian studies 4.1 vs 5.8 months (Nathani 2021)
211 days
Median for 43 untreated colorectal cancers (interquartile range 112–404 days) (Burke 2020)

In lung cancer, subsolid nodules grew significantly more slowly than solid ones
(Henschke 2012).
In liver cancer, factors linked with rapid growth included hepatitis B, smaller tumour size, and poor differentiation
(Nathani 2021).
In untreated colorectal cancer patients, who were mostly elderly (median age 80), with a median of 150 days between CT scans, tumour volume grew by a median of 34.1% per 62 days and T category increased in 31 of 43 tumours
(Burke 2020)
— showing that delays of several months do matter, even for cancers that are not fast.

Reassuring math: doubling the volume adds only about 26% to the diameter

A tumour is three-dimensional, so volume scales with the cube of the diameter. When volume doubles,
the diameter grows by only about 26% (the cube root of 2 ≈ 1.26). For example, a 2.0 cm tumour becomes about 2.5 cm after one doubling time.
Volume must increase 8-fold (3 doubling times) for the diameter to double.

Worked example: how much does a tumour grow in a 4-week wait?

Suppose a 2.0 cm tumour has a doubling time of 100 days (close to the median for screen-detected lung cancer). A 28-day wait raises its volume by about 21%, but its diameter by only about 7%, to roughly 2.13 cm.
If it were a fast cancer with a 30-day doubling time, volume would nearly double over the same period and the diameter would reach about 2.5 cm.
This is why the type of cancer matters more than the number of weeks, and why tumours close to the next size threshold, or fast-growing types, should be expedited.

Table: growth speed by cancer type from research, and what it means while waiting for tests

Numbers come from study groups, not individual predictions — real speed depends on subtype, grade, and the person

Growth speed of cancer types from verifiable data
Cancer typeTypical speedResearch dataMeaning during workup
Lung cancer found on CT screeningModerate, highly variableMedian doubling time 98 days; half under 100 days; 3% over 400 days; subsolid nodules slower (Henschke 2012)Planned workup is fine, but should not slip by months
Small-cell lung cancerFastClassed as rapidly growing; symptoms can mimic inflammation or infection and delay diagnosis (Harris 2012)Usually treated as urgent; ask about expediting
Liver cancer (HCC)Moderate, highly variablePooled 4.6 months; 35% rapid; 37.6% indolent; Asia 4.1 months (Nathani 2021)Hepatitis B or high grade may mean faster growth
Colorectal cancerSlow to moderateMedian doubling time 211 days (112–404 days) in untreated patients (Burke 2020)A few weeks unlikely to change stage, but months matter
Hormone-positive breast cancer (luminal A/B)SlowGrowth 0.175–0.208% per day; clinical size category up in 2–3% during a median 31-day wait for surgery (Lee 2016)Biomarker testing and planning can proceed as scheduled
Triple-negative or HER2-positive breast cancerFasterGrowth 1.003% and 0.859% per day; clinical size category up in 18% and 14% over the same wait (Lee 2016)Move to treatment as quickly as possible
Localised prostate cancer (PSA-detected)Mostly slow (years)15-year prostate cancer death 2.7%; metastases 9.4% with monitoring vs 4.7–5.0% with treatment (Hamdy 2023)Many can choose monitoring, but need regular checks
Burkitt lymphoma and testicular germ-cell tumoursVery fastClassed as rapidly growing cancers (Harris 2012)Should not wait in a routine queue; teams usually expedite
Acute leukaemia (AML)Very fastUsually gets worse quickly if not treated (NCI)An urgent condition, not a routine-queue cancer

3. Cancer stage is not a size ladder

Direct answer: stage looks at three things together — tumour size and extent, lymph-node involvement, and spread to distant organs.
So cancer does not “move from stage 1 to 2 to 3” step by step over time like climbing stairs.

What the TNM system looks at

  • T (Tumour) — size of the primary tumour and how far it has grown into nearby tissue
  • N (Node) — number and location of nearby lymph nodes that contain cancer
  • M (Metastasis) — whether cancer has spread to distant organs; if so, it is stage 4 no matter how small the primary tumour is

Examples where stage does not match size

A tumour that grows slightly but stays within the same T size category keeps the same stage.
Conversely, a small tumour that has reached lymph nodes may be a higher stage than a larger tumour that has not.
Size thresholds and stage groupings also differ between organs, and some cancers use their own systems, such as blood cancers and brain tumours.

The stage at diagnosis stays the reference

The US National Cancer Institute (NCI) explains that a cancer is always referred to by the stage it was given at diagnosis, even if it gets worse or spreads.
New information is added to the original stage, so the stage does not change, even though the cancer might
(NCI — Cancer Staging).
Clinically, if the disease grows or comes back, doctors call it progression or recurrence and restage it to plan treatment —
they do not write “moved from stage 1 to stage 2” on paper.

How urgent are your symptoms while waiting for tests or treatment?

Assess your severity level and get personalised guidance from our Advisory team.

The score helps grade the urgency of symptoms during cancer care — it does not diagnose any disease. If you have any symptom in the red-flag section, contact your team or go to hospital now.

Take the free cancer care urgency score

4. Waiting a few weeks for biopsy results, scans, or a treatment slot: how dangerous is it?

Direct answer: a planned few weeks of diagnosis and planning is part of standard care, and for most common solid tumours it is unlikely to change the stage in that time.
But it is not a guarantee for every person or every cancer — a complete workup matters, and avoidable delays matter too.

Why the workup must be complete before treatment

  • Biopsy — confirms that it is cancer and which type
  • Pathology and special stains (immunohistochemistry) — defines subtype and grade, which sometimes takes extra time
  • Biomarkers and genes — such as hormone receptors and HER2 in breast cancer, or gene tests in lung and bowel cancer, which decide which drugs will work
  • Staging scans — CT, MRI, PET-CT, or other tests depending on the cancer, to see how far it has spread
  • Multidisciplinary team meeting — surgeons, oncologists, radiologists, and pathologists decide the best treatment order

Starting treatment before results are complete can lead to the wrong choice, such as operating first when drugs should come first, or using a drug that does not work for that subtype.

Real data: breast cancer during a wait of about one month for surgery

A Korean study measured tumour size by ultrasound in 323 women with breast cancer at diagnosis and at surgery, with a median wait of 31 days (8–78 days).
Average size grew from 14.7 to 15.6 mm. Clinical size category (T) went up in 2% of luminal A and 3% of luminal B cancers,
but in 18% of triple-negative and 14% of HER2-positive cancers
(Lee 2016)
— most barely changed, but fast types really can change within weeks.

What delay in starting treatment means

A meta-analysis by Hanna and colleagues (BMJ 2020) combined 34 studies of about 1.27 million patients across 7 cancers (bladder, breast, colon, rectum, lung, cervix, and head and neck)
and found that each 4-week delay in starting treatment was associated with higher mortality:
about 6–8% for surgery (colectomy 6%, breast surgery 8%),
1–28% for systemic treatment depending on the indication,
and 9% for radical radiotherapy in head and neck cancer (23% for adjuvant radiotherapy in cervical cancer, with a wide confidence interval).
The association was significant in 13 of 17 indications
(Hanna 2020).

Delay in this study was measured from diagnosis to first treatment, or from one treatment to the next.
These are observational, population-level data — they do not mean everyone who waits 4 weeks will do worse, but they clearly show that health systems and patients should work together to cut avoidable delays.

How to keep a wait from becoming a delay

  • Keep every appointment. If you must reschedule, get a new date before you hang up
  • Always ask “Roughly what day will the biopsy or scan results be ready?” and write it down
  • If that date passes with no news, call and chase — results can get stuck or lost
  • Ask what you are waiting for right now: the biopsy, special stains, gene tests, a scan, or the team meeting
  • If symptoms get worse while waiting, tell the team and ask whether your pathway can be expedited — do not wait for the appointment
  • If you are referred elsewhere, take copies of results, biopsy slides, and images so testing does not restart. Read biopsy guide and how to transfer hospitals without restarting

5. What actually helps while you wait

Direct answer: what truly helps is getting your body and paperwork ready for treatment, so you tolerate surgery, drugs, or radiotherapy better and lose no time when your slot comes.

  • Eat enough, especially protein and calories — meat, fish, eggs, milk, beans. If you are eating little or losing weight, tell the team and ask to see a dietitian
  • Stay lightly active every day as you can, such as walking, to keep muscle strength
  • Stop smoking — it helps your body get ready for surgery and treatment
  • Sleep and manage stress — talk with someone you trust; ask for a nurse or psychologist if you cannot sleep or feel very anxious
  • Gather documents — biopsy reports, blood tests, CT/MRI images or reports, referral letters, and insurance or coverage details
  • Make a full medication list, including herbs and supplements, for the team, because some affect bleeding or interact with other drugs
  • Write down questions for the team — type and stage, treatment plan, expected waiting time, and who to contact if symptoms worsen
  • Choose one family member as coordinator — to track appointments, chase results, and come to consultations
Expensive supplements or herbs are not a shortcut — there is no evidence that they slow tumour growth, and some may interfere with drugs or increase bleeding.
See an example in Does papaya leaf cure cancer? Myth vs fact

Anxiety while waiting is normal

Waiting for results is often the most stressful stretch. Knowing what you are waiting for, when results are due, and which symptoms mean you should come back early helps reduce the feeling of losing control.
Family can help by listening and coordinating. Read more in caregiver support for advanced cancer.

6. The path from finding a lump to starting treatment: what to ask at each step

Direct answer: each step has a reason, and at every step you should know the expected completion date. If a step runs late, call and chase.

Lump or abnormal resultAsk which tests come next and when they are booked
BiopsyAsk when results will be ready and who will tell you
Pathology, stains, genesAsk what extra tests are pending and why
Staging scans (TNM)Ask whether an earlier scan slot exists if symptoms worsen
Team meeting, then treatmentAsk the start date and what to prepare

7. Comparison table: wait as planned, or expedite?

Direct answer: with no new symptoms and a cancer that is not fast-growing, a planned workup wait is normal — but late results, a fast-growing type, worsening symptoms, or red flags mean you should push to expedite.

Table: situations while waiting, what to do, and time frames

Summarised from the research in this article — the treating team decides the actual order of the queue

Wait as planned or expedite: situations and actions
SituationExamplesWhat to doTime frameReason / evidence
Planned workup, no new symptomsWaiting for biopsy, special stains, gene tests, staging scans, team meetingKeep appointments, ask result dates, prepare body and documentsUsually a few weeksComplete results guide the right treatment; hormone-positive breast cancer size category rose in only 2–3% over about 31 days
Results overdue or slot postponedNo word on biopsy, scan rescheduled, unsure what you are waiting forCall and chase, ask for a firm date, ask which step is stuckFollow up as soon as the promised date passesEach 4-week treatment delay was associated with higher mortality (surgery 6–8%) (Hanna 2020)
Referral to another hospitalMoving to a cancer centre or a hospital under your coverageTake copies of results, biopsy slides, images, and the referral letterPrepare before you arriveAvoids repeat testing and time lost in transfer
Fast-growing cancer typeSmall-cell lung cancer, Burkitt lymphoma, acute leukaemia, testicular cancer, triple-negative or HER2-positive breast cancerAsk the team directly whether your pathway should be expeditedTeams usually treat as urgentTriple-negative size category rose in 18% and HER2-positive in 14% over about 31 days (Lee 2016)
Symptoms slowly worseningMore pain, eating less, losing weight, a palpable lump getting biggerTell the team and ask for the pathway to be expeditedPromptly, without waiting for the appointmentChanging symptoms are key information for the team to set urgency
Red-flag symptomsBleeding, bowel obstruction, jaundice, breathlessness, back pain with leg weakness, seizure, fever of 38.0°C or higher on chemotherapyContact the team today or go to the emergency departmentSame dayThese need urgent treatment regardless of the routine queue
Preparing your body while waitingEnough protein and calories, light walking, stopping smoking, enough sleepStart today; tell the team about every drug and supplementThroughout the waitHelps you tolerate treatment — not a way to slow the cancer

Frequently asked questions (FAQ)

How many weeks or months does cancer take to spread from stage 1 to stage 2 to stage 3?

There is no single number that fits everyone. Speed depends on the cancer type, subtype, grade, and the individual. Many common solid tumours, such as many hormone-positive breast cancers, colorectal cancers, and many prostate cancers, usually grow over months to years. Some cancers are fast and can change over weeks, such as small-cell lung cancer, Burkitt lymphoma, acute leukaemia, testicular germ-cell tumours, and triple-negative or HER2-positive breast cancer. Stage also does not depend on size alone. It also depends on lymph-node involvement and distant spread.

What is cancer doubling time and how long is it?

Doubling time is the time it takes for a tumour to double in volume. It ranges from days to years, and there is no single average for all cancers. Examples from research: lung cancers found on CT screening had a median of 98 days, hepatocellular carcinoma had a pooled meta-analysis value of about 4.6 months, and untreated colorectal cancers had a median of 211 days. A reassuring fact is that when volume doubles, diameter grows by only about 26 percent, because the cube root of 2 is about 1.26.

Will cancer move to the next stage while I wait a few weeks for biopsy results or scans?

For most common solid tumours, a planned workup of a few weeks is unlikely to change the stage, but that is not a guarantee for everyone. In a study of 323 women with breast cancer who waited a median of 31 days for surgery, average size grew from 14.7 to 15.6 millimetres. Clinical size category went up in only 2 to 3 percent of hormone-positive cancers, but in 18 percent of triple-negative and 14 percent of HER2-positive cancers. A complete workup is needed to choose the right treatment, so keep appointments, ask when results are due, and chase late results.

How long can cancer treatment be delayed before it affects outcomes?

A meta-analysis by Hanna and colleagues in the BMJ in 2020, covering 34 studies in 7 cancers, found that each 4-week delay in starting treatment was associated with higher mortality: about 6 to 8 percent for surgery, 1 to 28 percent for systemic treatment depending on the indication, and about 9 percent for radical radiotherapy in head and neck cancer. The association was significant in 13 of 17 indications. These are observational, population-level data. They do not mean everyone who waits 4 weeks will do worse, but avoidable delay should be kept as short as possible.

Which cancers grow fast and should not wait in a routine queue?

Cancers that often grow fast include small-cell lung cancer, Burkitt lymphoma and some other high-grade lymphomas, acute leukaemia, which usually gets worse quickly without treatment, testicular germ-cell tumours, and triple-negative, HER2-positive, or high-grade breast cancer. Treating teams usually handle these as urgent. If you hear one of these names in your results, or symptoms change within days, ask the team directly whether your pathway should be expedited.

If the tumour grows while I wait, will my stage change from stage 1 to stage 2?

Stage is not a size ladder. The TNM system looks at tumour size and extent, lymph-node involvement, and distant spread. A tumour that grows slightly but stays within the same size category keeps the same stage, while a small tumour that has reached lymph nodes may be a higher stage than a larger one that has not. According to the US National Cancer Institute, a cancer is always referred to by the stage given at diagnosis. If it later progresses or recurs, doctors restage it and add the new information, rather than rewriting the original stage.

What should I do while waiting for cancer treatment, and can supplements slow the cancer down?

What truly helps is preparing your body to tolerate treatment: eat enough protein and calories, stay lightly active, stop smoking, sleep, manage stress, gather your test results and a full medication list, and write down questions for the team. There is no evidence that supplements or herbs slow tumour growth, and some can interact with drugs or increase bleeding, so tell the team before using any of them.

Which symptoms while waiting for tests or treatment should never wait for the appointment?

Do not wait for your slot if you notice a lump growing visibly within days, vomiting or coughing blood, heavy rectal or vaginal bleeding, black stools, being unable to eat or drink or repeated vomiting, severe bloating with no stool or gas, new jaundice, worsening breathlessness or chest pain, new severe back pain with leg weakness, numbness, or loss of bladder or bowel control, severe headache, confusion, a seizure, or one-sided weakness, fever of 38.0 °C or higher while on chemotherapy, or rapid weight loss with extreme weakness. Contact your treating team the same day or go to the emergency department.

Scientific mechanism

Mechanism summary by :
a tumour grows when more cells divide than die. Its real speed depends on three things — the share of cells actively dividing (growth fraction), the length of the cell cycle, and the rate of cell death or shedding.
High grade and a high Ki-67 index reflect fast division, so they go with short doubling times.

Most tumours do not keep doubling at a constant rate forever: they grow fast early and slow as they enlarge (Gompertzian growth), because the core runs short of blood and oxygen.
A tumour must trigger new blood vessel formation (angiogenesis) to keep growing, consistent with liver cancer data showing that smaller tumours tended to grow faster.
Because volume scales with the cube of the diameter, doubling the volume increases the diameter by only about 26%.

Spread to lymph nodes or distant organs does not depend on size alone, but on the ability of cells to invade tissue, enter lymphatic or blood vessels, and settle in other organs.
That is why some small tumours spread early while some large tumours stay local — and why TNM must consider T, N, and M, and stage is not a size ladder.

E-E-A-T and academic citations

Compiled by (ผศ.ดร.นรวิชญ์ ราษฎร์พิบูลย์) — synthesised from PubMed research and the US National Cancer Institute (NCI, NIH)


Medical disclaimer

This content is general education about how fast cancers grow, cancer staging, and the period of waiting for tests or treatment. It is not a diagnosis, prognosis, or personal treatment plan.
Numbers in this article come from study populations and mathematical calculation and cannot predict how fast any individual cancer will grow. Queue order and urgency are decided by the medical team caring for the patient directly.
If you have any symptom in the red-flag section, contact your treating team or go to the emergency department immediately.